Alteogen Inc news

19 September 2025
Merck Gains EU CHMP Support for KEYTRUDA SC and New Head and Neck Cancer Use
CHMP backs KEYTRUDA SC for all EU adult indications and a new use in LA-HNSCC. Awaiting European Commission's final decision.

What's Alteogen Inc up to in Europe?

Find out with chemXplore Analytics